Fresh Equities

Raises

Markets

About

Looking for more information?

Contact our responsive and friendly client services team any time.

ASX:CBL logo

ASX:CBL

Control Bionics Limited

Health Care / Biotechnology

Current price

$0.54

0.03 (5.26%)

Last trade: Invalid date GMT

Market cap

$27.12m

20 min delay

Investor Presentations

Principal Activity

Control Bionics designs, manufactures and sells wireless wearable electromyography (EMG) based augmentative and alternative communication (AAC) technology. This allows users to operate and communicate via a computer using intentional thought and the body’s own neuroelectric signals detected at skeletal muscle sites – the physical movement of a muscle is not necessary for the technology to detect and interface. Control Bionics is a pioneer in the field of neuroelectric control as the technology uses smart algorithms to detect, synthesise and convert EMG signals into code which can interface with and control a broad range of electronic devices.


News

Announcements

Filter

All categories
Investor Presentations
Trading Halt
Qtly Cashflow
Issued Capital
Periodic Reports
AnnouncementT+2 MovementDate

Rows per page:

5

0-0 of 0

Market Data

Day

3m

1yr

5yr

Current price

$0.54

Open price

-

Day low-high

-

Price change

-

Percent change

-

Previous close

-

Volume

-

Turnover

-

Bid price

-

Ask price

-

Market cap

-

Shares outstanding

-

Year high

-

Year low

-

Year low-high

-

Earnings per share

-

Price/earnings ratio

-

Dividend yield

-

Dividend per share

-

Franking

-

Investor Presentations

News

Sector Peers

CompanyMarket Cap
Fresh Equities
App Store
Play Store

Copyright © 2021 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9661 0441

clients@freshequities.com

Address

Level 19, 15 William St
Melbourne VIC 3000
Australia

App Store
Play Store

Copyright © 2021 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.